Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Short-term Investments (2016 - 2021)

Historic Short-term Investments for Sanofi (SNYNF) over the last 13 years, with Q4 2021 value amounting to $12.5 million.

  • Sanofi's Short-term Investments fell 9318.24% to $12.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $12.5 million, marking a year-over-year decrease of 9318.24%. This contributed to the annual value of $12.9 million for FY2021, which is 9263.54% down from last year.
  • Per Sanofi's latest filing, its Short-term Investments stood at $12.5 million for Q4 2021, which was down 9318.24% from $182.9 million recorded in Q4 2020.
  • Sanofi's Short-term Investments' 5-year high stood at $227.1 million during Q4 2018, with a 5-year trough of $12.5 million in Q4 2021.
  • For the 5-year period, Sanofi's Short-term Investments averaged around $132.0 million, with its median value being $147.0 million (2019).
  • As far as peak fluctuations go, Sanofi's Short-term Investments soared by 17086.46% in 2017, and later tumbled by 9318.24% in 2021.
  • Quarter analysis of 5 years shows Sanofi's Short-term Investments stood at $90.7 million in 2017, then soared by 150.53% to $227.1 million in 2018, then plummeted by 35.28% to $147.0 million in 2019, then rose by 24.42% to $182.9 million in 2020, then tumbled by 93.18% to $12.5 million in 2021.
  • Its last three reported values are $12.5 million in Q4 2021, $182.9 million for Q4 2020, and $147.0 million during Q4 2019.